http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013256543-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6107abcc76ad54b3821249d6315e0ab |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08 |
| filingDate | 2013-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6933dd68832a6d6014b9e5a6f840b381 |
| publicationDate | 2013-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013256543-A |
| titleOfInvention | Composition for external use |
| abstract | An external composition having an excellent elastase activity inhibitory action is provided. (A) pyrroloquinoline quinone, or a physiologically acceptable salt thereof, (b) EDTA or a physiologically acceptable salt thereof, and (c) 0.1 to 50 parts by weight of propylene glycol, 1,3-butylene glycol, dipropylene glycol, glycerin, isoprene glycol, diglycerin, ethylene glycol monomethyl ether, and at least one hydroxyl group-containing compound selected from the group consisting of diethylene glycol monoethyl ether, and a hydroxyl group-containing compound (c) Content of pyrroloquinoline quinone or physiologically acceptable salt thereof (a) is 5 parts by weight or more, and EDTA or physiologically acceptable salt (b) thereof The amount is 0.001 to 100 parts by weight with respect to 1 part by weight of pyrroloquinoline quinone or a physiologically acceptable salt thereof (a). Composition. [Selection] Figure 3 |
| priorityDate | 2011-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.